Quantitative proteomic discovery of dynamic epigenome changes that control human cytomegalovirus (HCMV) infection
about
Intricate Roles of Mammalian Sirtuins in Defense against Viral PathogensThe Promise of Proteomics in the Study of Oncogenic Viruses.The life cycle and pathogenesis of human cytomegalovirus infection: lessons from proteomicsCharacterization of histone post-translational modifications during virus infection using mass spectrometry-based proteomics.Manipulation of host pathways by human cytomegalovirus: insights from genome-wide studies.Epigenetic regulation of human cytomegalovirus latency: an update.Analysis of EV71 infection progression using triple-SILAC-based proteomics approach.The upstreams and downstreams of H3K79 methylation by DOT1L.The landscape of viral proteomics and its potential to impact human health.The therapeutic potential of epigenetic manipulation during infectious diseases.Cellular responses to human cytomegalovirus infection: Induction of a mesenchymal-to-epithelial transition (MET) phenotype.Determining the Mitochondrial Methyl Proteome in Saccharomyces cerevisiae using Heavy Methyl SILAC.Plasma L-Carnitine and L-Lysine Concentrations in HIV-Infected Patients.Epigenetic control of influenza virus: role of H3K79 methylation in interferon-induced antiviral response.
P2860
Q26778563-2A9867D1-40A3-48BD-A65C-A024BC407BB4Q34549700-7E754B89-0005-44B1-99D5-13EE70A78AFDQ36159634-FF2A450D-B215-4DEA-8CF8-FBD86257830CQ36304966-4F9F8535-FE72-4A54-975A-5B6629DA03A5Q38254758-D878AAC8-35D5-424A-8724-0A45A14F3B77Q38272313-191D899C-50F2-46A2-875F-B483D096FCCFQ38405180-EE86E530-8BB2-40A9-A2FA-CD571D519472Q38686217-887FADC2-595B-4276-B4A5-2E6AA2E13B15Q38822395-C647179D-C93B-4B16-AACC-48DC8C924362Q38926320-C481D1C0-CE34-498B-B743-8F80CE904F8DQ40056844-75FBD81E-CDCB-4FF9-B116-2D9DF72D07CBQ46388020-B5856A59-E3AD-45D8-B8E4-CD5BBADD5A7CQ47547367-1E03AF22-5C1E-49EB-8890-9D5C133839A0Q47551113-A186BA4D-05B3-4219-BE95-E99A5CD81891
P2860
Quantitative proteomic discovery of dynamic epigenome changes that control human cytomegalovirus (HCMV) infection
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Quantitative proteomic discove ...... tomegalovirus (HCMV) infection
@ast
Quantitative proteomic discove ...... tomegalovirus (HCMV) infection
@en
Quantitative proteomic discove ...... control human cytomegalovirus
@nl
type
label
Quantitative proteomic discove ...... tomegalovirus (HCMV) infection
@ast
Quantitative proteomic discove ...... tomegalovirus (HCMV) infection
@en
Quantitative proteomic discove ...... control human cytomegalovirus
@nl
prefLabel
Quantitative proteomic discove ...... tomegalovirus (HCMV) infection
@ast
Quantitative proteomic discove ...... tomegalovirus (HCMV) infection
@en
Quantitative proteomic discove ...... control human cytomegalovirus
@nl
P2093
P2860
P356
P1476
Quantitative proteomic discove ...... tomegalovirus (HCMV) infection
@en
P2093
Benjamin A Garcia
Christine M O'Connor
Thomas Shenk
P2860
P304
P356
10.1074/MCP.M114.039792
P577
2014-07-01T00:00:00Z